Aortic pulse wave velocity in patients with metabolic syndrome and hypertension treated with sartans;Rychlost aortální pulzové vlny u nemocných s metabolickým syndromem a hypertenzí léčených sartany

Vnitrni Lekarstvi

Volumn 56, Issue 8, 2010, Pages 880-883

  Špác, Jiří ^a   Soucek M ^a   Rihacek I ^a   Nemcova H ^a   Pluhacek L ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Aortic pulse wave; Hypertension; Metabolic syndrome; Sartans

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

AORTA; BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATHOPHYSIOLOGY; PULSE RATE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; AORTA; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PULSE;

EID: 77956587621     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Laurent S, Cockcroft J, Van Bortel L et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605. (Pubitemid 44627304)
2. Asmar R, Gosse P, Topouchian J et al. Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension. J Renin Angiotensin Aldosterone Syst 2002; 3: 176-180. (Pubitemid 35345616)
3. Widimsky J Jr, Petrák O, Štrauch B et al. Ovlivnění periferního a centrálního krevního tlaku losartanem. Cor Vasa 2010; 52: 183-186.
4. Karalliedde J, Smith A, DeAngelis L et al. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertension 2008; 51: 1617-1623.
5. Reid JL. Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension? J Renin Angiotensin Aldosterone Syst 2005; 6: 15-24.
6. Tropeano AI, Boutouyrie P, Pannier B et al. Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives. Hypertension 2006; 48: 80-86.